| Chlamydial Infection |
0 |
0.99 |
| Preventive Screening |
0 |
1 |
| Pregnancy |
0 |
0.5 |
| Gonorrhea |
0 |
0.98 |
| Clinical Guidelines |
0 |
0.21 |
| Child |
0 |
0.14 |
| Health Care Reform |
0 |
0.95 |
| Outpatient Clinic |
0 |
0.14 |
| Revenue and Practice Management |
0 |
0.14 |
| Sexually Transmitted Infection |
0 |
0.14 |
| Grant |
0 |
0.1 |
| Patient Safety |
0 |
0.1 |
| Pelvic Inflammatory Disease |
0 |
0.1 |
| Epididymitis |
0 |
0.07 |
| Hospital |
0 |
0.07 |
| Social Determinants of Health |
0 |
0.07 |
| Financial Reimbursement |
0 |
0.06 |
| Adolescent Medicine |
0 |
0.04 |
| Adverse Effects |
0 |
0.04 |
| Alabama |
0 |
0.04 |
| Clinical Research |
0 |
0.04 |
| Erectile Dysfunction |
0 |
0.04 |
| Evidence-Based Medicine |
0 |
0.04 |
| Gonococcal Infection |
0 |
0.04 |
| Health Care Quality, Access, and Evaluation |
0 |
0.04 |
| Multiple Sclerosis |
0 |
0.04 |
| Oregon |
0 |
0.04 |
| Pathogenesis |
0 |
0.04 |
| Pharynx |
0 |
0.04 |
| Primary Care |
0 |
0.04 |
| Rectum |
0 |
0.04 |
| Rural Health |
0 |
0.04 |
| Urethra |
0 |
0.04 |
| Vagina |
0 |
0.04 |